Alcoholism and inflammation: Neuroimmunology of behavioral and mood disorders

Brain, Behavior, and Immunity

Volumn 25, Issue SUPPL. 1, 2011, Pages

  Kelley, Keith W ^a   Dantzer, Robert ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

2,3 Indoleamine 2; 3 Dioxygenase; Alcoholism; Depressive like behavior; Kynurenine; Pro inflammatory cytokines; Sickness behavior

Indexed keywords

ALPHA INTERFERON; BCG VACCINE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TRYPTOPHAN;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL BEHAVIOR; BEHAVIOR DISORDER; CATABOLISM; CELL ACTIVATION; CEREBROSPINAL FLUID ANALYSIS; CYTOKINE PRODUCTION; DEPRESSION; ENZYME ACTIVATION; HEPATITIS; HUMAN; INNATE IMMUNITY; MICROGLIA; MOOD CHANGE; MOOD DISORDER; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ALCOHOLISM; ANIMALS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; INFLAMMATION; MICE; MOOD DISORDERS; NEUROIMMUNOMODULATION; TOLL-LIKE RECEPTOR 4;

EID: 79955717804     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.12.013     Document Type: Review

References (89)

1. Achur R.N., Freeman W.M., Vrana K.E. Circulating cytokines as biomarkers of alcohol abuse and alcoholism. Journal of Neuroimmune Pharmacology 2010, 5:83-91.
2. Alfonso-Loeches S., Pascual-Lucas M., Blanco A.M., Sanchez-Vera I., Guerri C. Pivotal role of TLR4 receptors in alcohol-induced neuroinflammation and brain damage. Journal of Neuroscience 2010, 30:8285-8295.
3. Alho H., Sillanaukee P., Kalela A., Jaakkola O., Laine S., Nikkari S.T. Alcohol misuse increases serum antibodies to oxidized LDL and C-reactive protein. Alcohol and Alcoholism (Oxford, Oxfordshire) 2004, 39:312-315.
4. Badawy A.A., Doughrty D.M., Marsh-Richard D.M., Steptoe A. Activation of liver tryptophan pyrrolase mediates the decrease in tryptophan availability to the brain after acute alcohol consumption by normal subjects. Alcohol and Alcoholism (Oxford, Oxfordshire) 2009, 44:267-271.
5. Ban E., Milon G., Prudhomme N., Fillion G., Haour F. Receptors for interleukin-1 (alpha and beta) in mouse brain: mapping and neuronal localization in hippocampus. Neuroscience 1991, 43:21-30.
6. Belmaker R.H., Agam G. Major depressive disorder. The New England Journal of Medicine 2008, 358:55-68.
7. Berkenbosch F., van Oers J., del Rey A., Tilders F., Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987, 238:524-526.
8. Branchey L., Lieber C.S. Activation of tryptophan pyrrolase after chronic alcohol administration. Substance and Alcohol Actions/Misuse 1982, 3:225-229.
9. Brydon L., Walker C., Wawrzyniak A., Whitehead D., Okamura H., Yajima J., Tsuda A., Steptoe A. Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain, Behavior, and Immunity 2009, 23:217-224.
10. Buydens-Branchey L., Branchey M., Worner T.M., Zucker D., Aramsombatdee E., Lieber C.S. Increase in tryptophan oxygenase activity in alcoholic patients. Alcoholism, Clinical and Experimental Research 1988, 12:163-167.
11. Capuron L., Ravaud A. Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state. The New England Journal of Medicine 1999, 340:1370.
12. Capuron L., Ravaud A., Dantzer R. Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. Journal of Clinical Oncology 2000, 18:2143-2151.
13. Capuron L., Ravaud A., Neveu P.J., Miller A.H., Maes M., Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Molecular Psychiatry 2002, 7:468-473.
14. Crews F.T., Bechara R., Brown L.A., Guidot D.M., Mandrekar P., Oak S., Qin L., Szabo G., Wheeler M., Zou J. Cytokines and alcohol. Alcoholism, Clinical and Experimental Research 2006, 30:720-730.
15. Crews F.T., Nixon K. Mechanisms of neurodegeneration and regeneration in alcoholism. Alcohol and Alcoholism (Oxford, Oxfordshire) 2009, 44:115-127.
16. Cunningham E.T., Wada E., Carter D.B., Tracey D.E., Battey J.F., De Souza E.B. In situ histochemical localization of type I interleukin-1 receptor messenger RNA in the central nervous system, pituitary, and adrenal gland of the mouse. Journal of Neuroscience 1992, 12:1101-1114.
17. Dantzer R., Capuron L., Irwin M.R., Miller A.H., Ollat H., Perry V.H., Rousey S., Yirmiya R. Identification and treatment of symptoms associated with inflammation in medically ill patients. Psychoneuroendocrinology 2008, 33:18-29.
18. Dantzer R., Kelley K.W. Stress and immunity: an integrated view of relationships between the brain and the immune system. Life Sciences 1989, 44:1995-2008.
19. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 2008, 9:46-56.
20. Dantzer, R., O'Connor, J.C., Lawson, M.A., Kelley, K.W., 2010. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. doi:10.1016/j.psyneuen.2010.09.012.
21. Dunn A.J., Swiergiel A.H. Effects of interleukin-1 and endotoxin in the forced swim and tail suspension tests in mice. Pharmacology, Biochemistry, and Behavior 2005, 81:688-693.
22. Eisenberger N.I., Berkman E.T., Inagaki T.K., Rameson L.T., Mashal N.M., Irwin M.R. Inflammation-induced anhedonia: endotoxin reduces ventral striatum responses to reward. Biological Psychiatry 2010, 68:748-754.
23. Farrar W.L., Kilian P.L., Ruff M.R., Hill J.M., Pert C.B. Visualization and characterization of interleukin 1 receptors in brain. Journal of Immunology 1987, 139:459-463.
24. Fernandez-Lizarbe S., Pascual M., Gascon M.S., Blanco A., Guerri C. Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages. Molecular Immunology 2008, 45:2007-2016.
25. French R.A., VanHoy R.W., Chizzonite R., Zachary J.F., Dantzer R., Parnet P., Bluthe R.M., Kelley K.W. Expression and localization of p80 and p68 interleukin-1 receptor proteins in the brain of adult mice. Journal of Neuroimmunology 1999, 93:194-202.
26. French R.A., Zachary J.F., Dantzer R., Frawley L.S., Chizzonite R., Parnet P., Kelley K.W. Dual expression of p80 type I and p68 type II interleukin-I receptors on anterior pituitary cells synthesizing growth hormone. Endocrinology 1996, 137:4027-4036.
27. Frenois F., Moreau M., O'Connor J.C., Lawson M., Micon C., Lestage J., Kelley K.W., Dantzer R., Castanon N. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology 2007, 32:516-531.
28. Fuchs, D., Moller, A.A., Reibnegger, G., Stockle, E., Werner, E.R., Wachter, H., 1990. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms. Journal of Acquired Immune Deficiency Syndromes (1999) 3, 873-876.
29. Galea I., Bechmann I., Perry V.H. What is immune privilege (not)?. Trends in Immunology 2007, 28:12-18.
30. Garg A.D., Nowis D., Golab J., Vandenabeele P., Krysko D.V., Agostinis P. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochimica et Biophysica Acta. 2010, 1805:53-71.
31. Godbout J.P., Moreau M., Lestage J., Chen J., Sparkman N.L., O'Connor J., Castanon N., Kelley K.W., Johnson R.W. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology 2008, 33:2341-2351.
32. Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Molecular Psychiatry 2008, 13:717-728.
33. Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Critchley H.D. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biological Psychiatry 2009, 66:407-414.
34. Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Dolan R.J., Critchley H.D. Neural origins of human sickness in interoceptive responses to inflammation. Biological Psychiatry 2009, 66:415-422.
35. Hart B.L. Biological basis of the behavior of sick animals. Neuroscience and Biobehavioral Reviews 1988, 12:123-137.
36. He J., Crews F.T. Increased MCP-1 and microglia in various regions of the human alcoholic brain. Experimental Neurology 2008, 210:349-358.
37. He J., Overstreet D.H., Crews F.T. Abstinence from moderate alcohol self-administration alters progenitor cell proliferation and differentiation in multiple brain regions of male and female P rats. Alcoholism, Clinical and Experimental Research 2009, 33:129-138.
38. Hendriks H.F., van Tol A. Alcohol. Handbook of Experimental Pharmacology 2005, 339:361.
39. Huang W., Tang Y., Li L. HMGB1, a potent proinflammatory cytokine in sepsis. Cytokine 2010, 51:119-126.
40. Irwin M.R., Olmstead R., Valladares E.M., Breen E.C., Ehlers C.L. Tumor necrosis factor antagonism normalizes rapid eye movement sleep in alcohol dependence. Biological Psychiatry 2009, 66:191-195.
41. Irwin M.F., Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain, Behavior, and Immunity 2007, 21:374-383.
42. Irwin M.R., Rinetti G. Disordered sleep, nocturnal cytokines, and immunity: interactions between alcohol dependence and African-American ethnicity. Alcohol (Fayetteville, NY) 2004, 32:53-61.
43. Johnson R.W., Gheusi G., Segreti S., Dantzer R., Kelley K.W. C3H/HeJ mice are refractory to lipopolysaccharide in the brain. Brain Research 1997, 752:219-226.
44. Kelley K.W. Cross-talk between the immune and endocrine systems. Journal of Animal Science 1988, 66:2095-2108.
45. Kelley K.W., Aubert A., Dantzer R. Inflammation and behavior. Eco-Immunology and Behavior 2011, Oxford University Press, Oxford, New York. G.E. Demas, R.J. Nelson (Eds.).
46. Kelley K.W., Weigent D.A., Kooijman R. Protein hormones and immunity. Brain, Behavior, and Immunity 2007, 21:384-392.
47. Kent S., Bluthe R.M., Dantzer R., Hardwick A.J., Kelley K.W., Rothwell N.J., Vannice J.L. Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. Proceedings of the National Academy of Sciences of the United States of America 1992, 89:9117-9120.
48. Kent S., Bluthe R.M., Kelley K.W., Dantzer R. Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences 1992, 13:24-28.
49. Kent S., Rodriguez F., Kelley K.W., Dantzer R. Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat. Physiology & Behavior 1994, 56:1031-1036.
50. Kessler R.C., McGonagle K.A., Zhao S., Nelson C.B., Hughes M., Eshleman S., Wittchen H.U., Kendler K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 1994, 51:8-19.
51. Koo J.W., Duman R.S. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:751-756.
52. Koo J.W., Russo S.J., Ferguson D., Nestler E.J., Duman R.S. Nuclear factor-kappaB is a critical mediator of stress-impaired neurogenesis and depressive behavior. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:2669-2674.
53. Lapin I.P., Oxenkrug G.F. Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet 1969, 293:132-136.
54. Laugeray A., Launay J.M., Callebert J., Surget A., Belzung C., Barone P.R. Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression. Behavioural Brain Research 2010, 210:84-91.
55. Lestage J., Verrier D., Palin K., Dantzer R. The enzyme indoleamine 2, 3-dioxygenase is induced in the mouse brain in response to peripheral administration of lipopolysaccharide and superantigen. Brain, Behavior, and Immunity 2002, 16:596-601.
56. Liukkonen T., Silvennoinen-Kassinen S., Jokelainen J., Rasanen P., Leinonen M., Meyer-Rochow V.B., Timonen M. The association between C-reactive protein levels and depression: results from the northern Finland 1966 birth cohort study. Biological Psychiatry 2006, 60:825-830.
57. Luo L., Rodriguez E., Jerbi K., Lachaux J.P., Martinerie J., Corbetta M., Shulman G.L., Piomelli D., Turrigiano G.G., Nelson S.B., Joels M., de Kloet E.R., Holsboer F., Amodio D.M., Frith C.D., Block M.L., Zecca L., Hong J.S., Dantzer R., Kelley K.W., Bud Craig A.D. Ten years of Nature Reviews Neuroscience. Insights from the highly cited. Nature Reviews 2010, 11:718-726.
58. Maes M., Smith R., Scharpe S. The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 1995, 20:111-116.
59. Malarkey W.B., Mills P.J. Endocrinology: the active partner in PNI research. Brain, Behavior, and Immunity 2007, 21:161-168.
60. Mallard, C., Wang, X., Hagberg, H., 2009. The role of Toll-like receptors in perinatal brain injury. Clinics in Perinatology 36, 763-772 (v-vi).
61. Mathew S.J., Charney D.S. Publication bias and the efficacy of antidepressants. The American Journal of Psychiatry 2009, 166:140-145.
62. Miller A.H. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain, Behavior, and Immunity 2009, 23:149-158.
63. Moreau M., Andre C., O'Connor J.C., Dumich S.A., Woods J.A., Kelley K.W., Dantzer R., Lestage J., Castanon N. Inoculation of Bacillus Calmette-Guerin to mice induces an acute episode of sickness behavior followed by chronic depressive-like behavior. Brain, Behavior, and Immunity 2008, 22:1087-1095.
64. Moreau M., Lestage J., Verrier D., Mormede C., Kelley K.W., Dantzer R., Castanon N. Bacille Calmette-Guerin inoculation induces chronic activation of peripheral and brain indoleamine 2, 3-dioxygenase in mice. The Journal of Infectious Diseases 2005, 192:537-544.
65. Musselman D.L., Lawson D.H., Gumnick J.F., Manatunga A.K., Penna S., Goodkin R.S., Greiner K., Nemeroff C.B., Miller A.H. Paroxetine for the prevention of depression induced by high-dose interferon alfa. The New England Journal of Medicine 2001, 344:961-966.
66. Nagata S., Taira H., Hall A., Johnsrud L., Streuli M., Ecsodi J., Boll W., Cantell K., Weissmann C. Synthesis in E. Coli of a polypeptide with human leukocyte interferon activity. Nature 1980, 284:316-320.
67. Nelson L.R., Taylor A.N., Lewis J.W., Poland R.E., Redei E., Branch B.J. Pituitary-adrenal responses to morphine and footshock stress are enhanced following prenatal alcohol exposure. Alcoholism, Clinical and Experimental Research 1986, 10:397-402.
68. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nature Neuroscience 2010, 13:1161-1169.
69. Norman G.J., Karelina K., Zhang N., Walton J.C., Morris J.S., Devries A.C. Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Molecular Psychiatry 2010, 15:404-414.
70. O'Connor J.C., Andre C., Wang Y., Lawson M.A., Szegedi S.S., Lestage J., Castanon N., Kelley K.W., Dantzer R. Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2, 3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. Journal of Neuroscience 2009, 29:4200-4209.
71. O'Connor J.C., Lawson M.A., Andre C., Briley E.M., Szegedi S.S., Lestage J., Castanon N., Herkenham M., Dantzer R., Kelley K.W. Induction of IDO by bacille Calmette-Guerin is responsible for development of murine depressive-like behavior. Journal of Immunology 2009, 182:3202-3212.
72. O'Connor J.C., Lawson M.A., Andre C., Moreau M., Lestage J., Castanon N., Kelley K.W., Dantzer R. Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2, 3-dioxygenase activation in mice. Molecular Psychiatry 2009, 14:511-522.
73. Parnet P., Amindari S., Wu C., Brunke-Reese D., Goujon E., Weyhenmeyer J.A., Dantzer R., Kelley K.W. Expression of type I and type II interleukin-1 receptors in mouse brain. Brain Research 1994, 27:63-70.
74. Parnet P., Brunke D.L., Goujon E., Mainard J.D., Biragyn A., Arkins S., Dantzer R., Kelley K.W. Molecular identification of two types of interleukin-1 receptors in the murine pituitary gland. Journal of Neuroendocrinology 1993, 5:213-219.
75. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 2006, 27:24-31.
76. Raison, C.L., Dantzer, R., Kelley, K.W., Lawson, M.A., Woolwine, B.J., Vogt, G., Spivey, J.R., Saito, K., Miller, A.H., 2009. CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Molecular Psychiatry.
77. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science (New York, NY) 1987, 238:522-524.
78. Segreti J., Gheusi G., Dantzer R., Kelley K.W., Johnson R.W. Defect in interleukin-1beta secretion prevents sickness behavior in C3H/HeJ mice. Physiology & Behavior 1997, 61:873-878.
79. Smith R.S. The macrophage theory of depression. Medical Hypotheses 1991, 35:298-306.
80. Spanagel R. Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiological Reviews 2009, 89:649-705.
81. Swendsen J.D., Merikangas K.R., Canino G.J., Kessler R.C., Rubio-Stipec M., Angst J. The comorbidity of alcoholism with anxiety and depressive disorders in four geographic communities. Comprehensive Psychiatry 1998, 39:176-184.
82. Taylor A.N., Branch B.J., Kokka N. Neuroendocrine effects of fetal alcohol exposure. Progress in Biochemical Pharmacology 1981, 18:99-110.
83. Valles S.L., Blanco A.M., Pascual M., Guerri C. Chronic ethanol treatment enhances inflammatory mediators and cell death in the brain and in astrocytes. Brain Pathology (Zurich, Switzerland) 2004, 14:365-371.
84. Watkins L.R., Maier S.F. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annual Review of Psychology 2000, 51:29-57.
85. Wright C.E., Strike P.C., Brydon L., Steptoe A. Acute inflammation and negative mood: mediation by cytokine activation. Brain, Behavior, and Immunity 2005, 19:345-350.
86. Yang L., Latchoumycandane C., McMullen M.R., Pratt B.T., Zhang R., Papouchado B.G., Nagy L.E., Feldstein A.E., McIntyre T.M. Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. The Journal of Biological Chemistry 2010, 285:22211-22220.
87. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Research 1996, 711:163-174.
88. Yirmiya R., Goshen I. Immune modulation of learning, memory, neural 816 plasticity and neurogenesis. Brain, Behavior, and Immunity 2011, 25:181-213.
89. Zhang P., Bagby G.J., Happel K.I., Raasch C.E., Nelson S. Alcohol abuse, immunosuppression, and pulmonary infection. Current Drug Abuse Reviews 2008, 1:56-67.